Yayıncı "BioMed Central" Dahili Tıp Bilimleri Bölümü için listeleme
Toplam kayıt 8, listelenen: 1-8
-
7Th Drug Hypersensitivity Meeting: Part One
(BioMed Central, 2016)Background: Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious, life threatening severe immune-mediated cutaneous reactions with mortality ranging from 10 to 30 %. The commonest causes are ... -
Allergen Immunotherapy for Allergic Asthma: A Systematic Overview of Systematic Reviews
(BioMed Central, 2017)Background: There is clinical uncertainty about the effectiveness and safety of allergen immunotherapy (AIT) for the treatment of allergic asthma. Objectives: To undertake a systematic overview of the effectiveness, ... -
Comparison Of Proteins, Lethality And Immunogenic Compounds Of Androctonus Crassicauda (Olivier, 1807) (Scorpiones : Buthidae) Venom Obtained By Different Methods
(BioMed Central, 2007)Scorpions are venomous arthropods of the class Arachnida and are considered relatives of spiders, ticks and mites. There are approximately 1,500 species of scorpions worldwide, which are characterized by an elongated body ... -
Determinants Of Early Initiation Of Breastfeeding In Nigeria: A Population-Based Study Using The 2013 Demograhic And Health Survey Data
(BioMed Central, 2016)Background Provision of mother’s breast milk to infants within one hour of birth is referred to as Early Initiation of Breast Feeding (EIBF) which is an important strategy to reduce perinatal and infant morbidities and ... -
Effect of Haemodiafiltration Vs Conventional Haemodialysis on Growth and Cardiovascular Outcomes in Children - The Hdf, Heart and Height (3H) Study
(BioMed Central, 2018)Background: Cardiovascular disease is prevalent in children on dialysis and accounts for almost 30% of all deaths. Randomised trials in adults suggest that haemodiafiltration (HDF) with high convection volumes is associated ... -
Efficacy, Safety And Population Pharmacokinetics Of Sapropterin In Pku Patients < 4 Years: Results From The Spark Open-Label, Multicentre, Randomized Phase Iiib Trial
(BioMed Central, 2017)Background: Sapropterin dihydrochloride, a synthetic formulation of BH4, the cofactor for phenylalanine hydroxylase (PAH, EC 1.14.16.1), was initially approved in Europe only for patients >= 4 years with BH4-responsive ... -
Hyperferritinemia In The Critically Ill Child With Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome: What Is The Treatment?
(BioMed Central, 2012)Introduction: Hyperferritinemia is associated with increased mortality in pediatric sepsis, multiple organ dysfunction syndrome (MODS), and critical illness. The International Histiocyte Society has recommended that children ... -
Mefv Mutations In Systemic Jia
(BioMed Central, 2008)Background: Systemic form of juvenile idiopathic arthritis (JIA) is regarded as an autoinflammatory disease. Certain genetic polymorphisms in genes coding inflammatory proteins have been associated with the disease. On the ...